SE9702776D0 - Method of preparing pharmaceutical compositions - Google Patents

Method of preparing pharmaceutical compositions

Info

Publication number
SE9702776D0
SE9702776D0 SE9702776A SE9702776A SE9702776D0 SE 9702776 D0 SE9702776 D0 SE 9702776D0 SE 9702776 A SE9702776 A SE 9702776A SE 9702776 A SE9702776 A SE 9702776A SE 9702776 D0 SE9702776 D0 SE 9702776D0
Authority
SE
Sweden
Prior art keywords
lipid
protein
pharmaceutical compositions
subjected
preparing pharmaceutical
Prior art date
Application number
SE9702776A
Other languages
English (en)
Inventor
Mattias Andersson
Dorota Johanson
Percy Li
Bjoern Norrlind
Bengt Westgren
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9702776A priority Critical patent/SE9702776D0/sv
Publication of SE9702776D0 publication Critical patent/SE9702776D0/sv
Priority to EP98934120A priority patent/EP1014947B1/en
Priority to PCT/SE1998/001407 priority patent/WO1999004761A1/en
Priority to CA002297924A priority patent/CA2297924C/en
Priority to DE69829191T priority patent/DE69829191T2/de
Priority to AU83718/98A priority patent/AU744738B2/en
Priority to SI9830749T priority patent/SI1014947T1/xx
Priority to DK98934120T priority patent/DK1014947T3/da
Priority to AT98934120T priority patent/ATE289806T1/de
Priority to NZ502840A priority patent/NZ502840A/xx
Priority to JP2000503821A priority patent/JP3813439B2/ja
Priority to PT98934120T priority patent/PT1014947E/pt
Priority to ES98934120T priority patent/ES2236919T3/es
Priority to NO20000330A priority patent/NO20000330L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9702776A 1997-07-22 1997-07-22 Method of preparing pharmaceutical compositions SE9702776D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9702776A SE9702776D0 (sv) 1997-07-22 1997-07-22 Method of preparing pharmaceutical compositions
ES98934120T ES2236919T3 (es) 1997-07-22 1998-07-22 Metodo para preparar composiciones farmaceuticas de particulas lipidicas que comprenden un agente lipidico y una proteina.
SI9830749T SI1014947T1 (sv) 1997-07-22 1998-07-22
PCT/SE1998/001407 WO1999004761A1 (en) 1997-07-22 1998-07-22 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein
CA002297924A CA2297924C (en) 1997-07-22 1998-07-22 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein
DE69829191T DE69829191T2 (de) 1997-07-22 1998-07-22 Verfahren zur herstellung pharmazeutischer zusammensetzungen von lipidpartikeln, enthaltend einen lipidwirkstoff sowie ein protein
AU83718/98A AU744738B2 (en) 1997-07-22 1998-07-22 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein
EP98934120A EP1014947B1 (en) 1997-07-22 1998-07-22 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein
DK98934120T DK1014947T3 (da) 1997-07-22 1998-07-22 Fremgangsmåde til fremstilling af farmaceutiske præparater af lipidpartikler omfattende et lipid-middel og et protein
AT98934120T ATE289806T1 (de) 1997-07-22 1998-07-22 Verfahren zur herstellung pharmazeutischer zusammensetzungen von lipidpartikeln, enthaltend einen lipidwirkstoff sowie ein protein
NZ502840A NZ502840A (en) 1997-07-22 1998-07-22 High pressure homogenisation method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein
JP2000503821A JP3813439B2 (ja) 1997-07-22 1998-07-22 脂質剤及びタンパク質を含む脂質粒子の医薬組成物の製造方法
PT98934120T PT1014947E (pt) 1997-07-22 1998-07-22 Metodo de preparacao de composicoes farmaceuticas de particulas lipidicas compreendendo um agente lipidico e uma proteina
NO20000330A NO20000330L (no) 1997-07-22 2000-01-21 FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702776A SE9702776D0 (sv) 1997-07-22 1997-07-22 Method of preparing pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SE9702776D0 true SE9702776D0 (sv) 1997-07-22

Family

ID=20407807

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702776A SE9702776D0 (sv) 1997-07-22 1997-07-22 Method of preparing pharmaceutical compositions

Country Status (12)

Country Link
EP (1) EP1014947B1 (sv)
JP (1) JP3813439B2 (sv)
AT (1) ATE289806T1 (sv)
AU (1) AU744738B2 (sv)
CA (1) CA2297924C (sv)
DE (1) DE69829191T2 (sv)
ES (1) ES2236919T3 (sv)
NO (1) NO20000330L (sv)
NZ (1) NZ502840A (sv)
PT (1) PT1014947E (sv)
SE (1) SE9702776D0 (sv)
WO (1) WO1999004761A1 (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206749B1 (en) * 1999-02-26 2012-06-26 Novartis Vaccines And Diagnostics, Inc. Microemulsions with adsorbed macromolecules and microparticles
EP1154807A1 (en) * 1999-12-22 2001-11-21 Surgical Sealants, Incorporated Methods and compositions for sealing tissue leaks
AU776767B2 (en) * 2000-02-02 2004-09-23 Florida State University Research Foundation, Inc. C10 heterosubstituted acetate taxanes as antitumor agents
US6514523B1 (en) * 2000-02-14 2003-02-04 Ottawa Heart Institute Research Corporation Carrier particles for drug delivery and process for preparation
US6682761B2 (en) * 2000-04-20 2004-01-27 Rtp Pharma, Inc. Water-insoluble drug particle process
US6599441B1 (en) 2000-07-18 2003-07-29 Emerald Biostructures, Inc. Crystallization solutions
US7803400B2 (en) 2002-12-03 2010-09-28 Blanchette Rockefeller Neurosciences Institute Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
WO2004050062A2 (en) * 2002-12-03 2004-06-17 Blanchette Rockefeller Neurosciences Institute Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
PL1613346T3 (pl) 2003-04-04 2013-03-29 Zoetis Services Llc Poddane mikrofluidyzacji emulsje typu olej w wodzie i kompozycje szczepionek
JP4050784B2 (ja) * 2005-02-03 2008-02-20 株式会社Ｎｒｌファーマ マトリックス型腸溶性・徐放性組成物
KR100902570B1 (ko) * 2005-03-28 2009-06-11 주식회사 리제론 단백질을 포위하는 나노리포좀의 제조방법 및 단백질-포위나노리포좀
WO2007076452A1 (en) * 2005-12-29 2007-07-05 Invitrogen Corporation Compositions and methods for improving resolution of biomolecules separated on polyacrylamide gels
EP1915986A1 (en) 2006-10-23 2008-04-30 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Lipid growth factor formulations
CH715456B1 (de) 2007-04-27 2020-04-30 Mibelle Ag Kosmetisches Produkt zur topischen Anwendung für den Schutz und die Erneuerung von Hautstammzellen, welches sich von dedifferenzierten Pflanzenzellen ableitet.
US8071759B2 (en) 2008-07-18 2011-12-06 Affymetrix, Inc. Water soluble cholesterol derivatives
CA2780482A1 (en) 2008-11-17 2010-05-10 Anil K. Sood Hdl particles for delivery of nucleic acids
KR101689787B1 (ko) 2009-08-31 2016-12-26 나노캐리어 가부시키가이샤 입자 조성물 및 이를 가진 의약 조성물
US20160346221A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128318A (en) * 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
IL86799A (en) * 1987-07-02 1993-03-15 Kabi Pharmacia Ab Method and device for injection
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins

Also Published As

Publication number Publication date
ES2236919T3 (es) 2005-07-16
AU8371898A (en) 1999-02-16
NZ502840A (en) 2002-08-28
CA2297924A1 (en) 1999-02-04
DE69829191T2 (de) 2005-07-21
EP1014947B1 (en) 2005-03-02
ATE289806T1 (de) 2005-03-15
JP2001510786A (ja) 2001-08-07
DE69829191D1 (de) 2005-04-07
JP3813439B2 (ja) 2006-08-23
CA2297924C (en) 2007-04-10
NO20000330D0 (no) 2000-01-21
EP1014947A1 (en) 2000-07-05
NO20000330L (no) 2000-03-21
PT1014947E (pt) 2005-05-31
AU744738B2 (en) 2002-02-28
WO1999004761A1 (en) 1999-02-04

Similar Documents

Publication Publication Date Title
SE9702776D0 (sv) Method of preparing pharmaceutical compositions
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
IL136085A0 (en) Prolamin-plant polar lipid combination, preparation method and applications
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
ATE239453T1 (de) Verfahren zur trennung von wirkstoffen in festen pharmazeutischen zubereitungen
AU649973B2 (en) Aromatic amine compounds, their method of preparation and pharmaceutical compositions in which they are present
FI953442A0 (sv) Frystorkade kulor innehållande gonadotropin
FR2567885B1 (fr) Derives 3-aminopropoxyaryliques, leur preparation, leur application comme medicaments et compositions pharmaceutiques les contenant
DK624287A (da) Komprimeret tablet eller kapsel
BR0014420A (pt) Composição farmacêutica, método para a preparação de uma composição farmacêutica, e, kit para preparar uma composição farmacêutica aquosa
HUP9700826A1 (hu) Peptikus fekély elleni gyógyászati készítmények
CA2335551A1 (en) Thyroid hormone analogues and methods for their preparation
UA35639C2 (uk) Спосіб одержання композиції очищеного капсидного білка вірусу папіломи людини
ATE233534T1 (de) Mittel zur behandlung keratinischer fasern
AU583255B2 (en) New benzenesulfonyl-lactams, process for their preparation and their use as active substances of pharmaceutical compositions
FR2763592B1 (fr) Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
GEP20022751B (en) Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water
DK0740547T3 (da) Liposomer indeholdende deri indkapslede proteiner, fremgangsmåde til deres fremstilling, samt farmaceutiske og kosmetiske p
ATE291058T1 (de) Vernetzerfreie zubereitungen
AU7655098A (en) Somatostatin and somatostatin agonists for decreasing body weight
PL333209A1 (en) Medical and cosmetic compositions, their applications and method of manufacturing
FR2565586B1 (fr) Derives de la naphtoxazine, leur preparation, leur application comme medicaments et compositions pharmaceutiques les contenant
FR2595703B1 (fr) Nouveaux phospholipides, leur procede et les intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
UA28265A (uk) Спосіб одержання екстракту алое
ES478422A3 (es) Un metodo de preparar una formulacion de tableta farmaceuti-ca.